- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06266780
Impact Evaluation of a Targeted mHealth Intervention to Improve Uptake of Postpartum Contraception in Kenya
The goal of this study is to explore approaches to improve postpartum contraceptive counseling, information, and uptake through a collaboration between the Harvard Chan School, Rutgers School of Public Health, Jacaranda Health, Jhpiego, and IPSOS, leveraging an existing mobile health platform for intervention delivery and Jacaranda's established partnership with the Kenyan Ministry of Health, county health offices and public maternity hospitals.
Jacaranda's PROMPTS mHealth platform has reached over two million pregnant women and new mothers, providing them with needed, tailored information about prenatal and postpartum health along with access to a mobile helpdesk to triage users' questions. Using a targeted human-centered-design process with early postpartum mothers, we developed targeted messaging around family planning and contraceptive method options, with the goal of integrating this new content into Jacaranda's PROMPTS platform. We will conduct a randomized controlled trial with pregnant women engaged with the PROMPTS platform to determine the impact of the intervention package on information and utilization of postpartum contraception. If proven effective, the results of this intervention will be integrated into Jacaranda's PROMPTS system at full scale.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anneka Wickramanayake, MPH
- Phone Number: 254 70 0164229
- Email: awickramanayake@jacarandahealth.org
Study Contact Backup
- Name: Jessica Cohen, Ph.D
- Phone Number: 617-432-7577
- Email: cohenj@hsph.harvard.edu
Study Locations
-
-
-
Nairobi, Kenya, 00000
- Recruiting
- Jacaranda Health
-
Contact:
- Anneka Wickramanayake, Masters
- Phone Number: +254700164229
- Email: awickramanayake@jacarandahealth.org
-
Contact:
- Jessica Cohen, Ph.D
- Phone Number: +16174327577
- Email: cohenj@hsph.harvard.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 15 and over,
- Pregnant at 7-8 months gestation,
- Consented to be enrolled in the PROMPTS text-messaging platform and who have provided informed consent to be part of this research study
- Have access to a mobile phone
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
Group receiving enhanced package of postpartum family planning support
|
Based on a targeted human-centered-design process with pregnant and early postpartum mothers, the intervention consists of informative messages, counselling and reminders regarding postpartum family planning and birth spacing, leveraging an existing mobile health platform (PROMPTS) for intervention delivery and Jacaranda's established partnership with the Kenyan Ministry of Health, county health offices and public maternity hospitals method options.
The intervention includes several features: activation of family planning discussions between pregnant and postpartum women and their health care providers, information provision, method selection support to help women choose their preferred method, and reminders to follow-up.
The key feature is to help women make an informed plan about family planning in the prenatal or early postpartum period and follow through with this plan.
|
|
No Intervention: Control Group
Group receiving basic postpartum family planning information
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Use of postpartum family planning at 3 months
Time Frame: 3 months
|
The outcome is a binary variable, set to 1 if a participant reports using any modern family planning method (including Lactational Amenorrhea Method (LAM)) at the time of the survey.
The modern methods considered will include sterilization (both male and female), implants, Intrauterine Device (IUD), injectables, oral contraceptives (pill), condoms (both male and female), diaphragm, foam/jelly, and LAM.
|
3 months
|
|
Use of postpartum family planning at 6 months
Time Frame: 6.5 months
|
The outcome is a binary variable, assigned a value of 1 if a participant reports using any modern family planning method, excluding LAM, at the time of the survey.
The modern methods considered include sterilization (both male and female), implant, IUD, injectables, oral contraceptives (pill), condoms (both male and female), diaphragm, foam, and jelly.
|
6.5 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge of return to fertility
Time Frame: 3 months postpartum
|
The outcome is a binary variable, set to 1 if a participant is aware of the possibility of becoming pregnant after giving birth, even if she has not yet seen her period
|
3 months postpartum
|
|
Knowledge of safe birth spacing
Time Frame: 3 months postpartum
|
The outcome is a binary variable, set to 1 if a participant is aware of the minimum recommended delay between the delivery of a baby and the start of the next pregnancy (two years) to promote the health of both the mother and the child.
|
3 months postpartum
|
|
Knowledge of lactational amenorrhea (LAM) method
Time Frame: 3 months postpartum
|
This outcome is an index assessing knowledge of LAM as a method to avoid or delay pregnancy and consists of three items.
The first item is a binary indicator, set to 1 if a participant has any familiarity with LAM.
The second item is a binary variable, set to 1 if the participant, among those familiar with LAM, knows the recommended duration of LAM use post-delivery (up to 6 months after delivery).
The third item is a binary variable, set to 1 if the participant, again among those familiar with LAM, is aware of the other two factors that can reduce the effectiveness of LAM (return of menstruation and the introduction of liquids/foods to the baby).
Participants who are not familiar with LAM will automatically receive a score of 0 for the second and third items.
|
3 months postpartum
|
|
Intention to continue family planning method
Time Frame: 3 and 6.5 months postpartum
|
The outcome is a binary variable, assigned a value of 1 if a participant reports an intention to continue using the same family planning method that they were using at the time of the survey.
|
3 and 6.5 months postpartum
|
|
Intended duration of continued family planning method use
Time Frame: 3 and 6.5 months postpartum
|
Among participants who reported an intention to continue with their current family planning method, this outcome quantifies the number of months they plan to maintain its use, as indicated during the survey.
|
3 and 6.5 months postpartum
|
|
Desired pregnancy spacing of two years or more
Time Frame: 3 months postpartum
|
This outcome assesses participants' intentions regarding birth spacing following their recent pregnancy. The primary focus is to determine the proportion of participants planning a gap of at least two years before the onset of their next pregnancy. Participants' intentions are categorized into:
|
3 months postpartum
|
|
Short interpregnancy interval
Time Frame: 3 and 6.5 months postpartum
|
The outcome is a binary variable, assigned a value of 1 if a participant reports being pregnant at either of the two follow-up surveys conducted at 3 months or 6.5 months.
|
3 and 6.5 months postpartum
|
|
Method satisfaction
Time Frame: 3 and 6.5 months postpartum
|
This outcome is a discrete variable with values ranging from 1 (very unsatisfied) to 5 (very satisfied), assessing overall satisfaction with the current family planning method.
It is evaluated only among participants who reported using a family planning method at the time of the survey.
|
3 and 6.5 months postpartum
|
|
Uptake of most effective family planning methods
Time Frame: 3 and 6.5 months postpartum
|
The outcome is a binary variable, set to 1 if a participant reports using any of the most effective family planning methods as classified by the US CDC at the time of the survey.
The subset of the most effective methods includes: implant, IUD, sterilization, injectable, pill, patch, diaphragm, and ring.
|
3 and 6.5 months postpartum
|
|
Time to take-up of most effective methods
Time Frame: 0-6.5 months postpartum
|
This outcome is a continuous time variable, measured in weeks, representing the interval between delivery and first adoption of one of the most effective methods of family planning, as classified by the CDC.
This outcome is calculated only for participants who reported using one or more of these most effective methods.
|
0-6.5 months postpartum
|
|
Discussion of FP at any prenatal visit
Time Frame: 3 months postpartum
|
The outcome is a binary variable, assigned a value of 1 if a participant reports having had a discussion about family planning with their antenatal care provider at any point during the prenatal period.
|
3 months postpartum
|
|
Discussion of FP at any postnatal visit
Time Frame: 3 months postpartum
|
The outcome is a binary variable, assigned a value of 1 if a participant reports having had a discussion about family planning with health staff at their postnatal care facility at any point during the postnatal period.
|
3 months postpartum
|
|
Reproductive empowerment: health care provider communication
Time Frame: 3 and 6.5 months postpartum
|
The outcome is an average score across 3 items measuring one aspect of reproductive empowerment: health care provider communication (participant reports being able to initiate conversations about using contraception with health care providers, ask health care provider questions about using contraception, and share opinions about using contraception with health care providers.)
|
3 and 6.5 months postpartum
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of helpdesk team in counselling on family planning
Time Frame: 6.5 months postpartum
|
This outcome is a discrete variable with values ranging from 1 (not helpful at all) to 5 (very helpful), indicating the quality of the helpdesk team's counseling on family planning methods.
This outcome is measured only among participants who have interacted with a helpdesk agent.
|
6.5 months postpartum
|
|
Quality of message flow on method selection
Time Frame: 6.5 months postpartum
|
This outcome is an index with scores ranging from 3 to 15, based on three items with discrete scales measuring the quality of the message flow from the PROMPTS platform regarding method selection.
Each item ranges from 1 (not helpful at all) to 5 (very helpful), assessing the usefulness of the messaging platform in: 1) educating about different family planning methods, 2) providing information related to any concerns or issues they had with family planning methods, and 3) assisting in the selection of a family planning method.
|
6.5 months postpartum
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Anneka Wickramanayake, MPH, Jacaranda Health
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- P1473-2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postpartum Family Planning
-
Stanford UniversityCompletedPostpartum Contraception | Family PlanningUnited States
-
Rush University Medical CenterUniversity of Illinois at Chicago; AllianceChicagoCompletedContraception | Family Planning | PostPartumUnited States
-
Services Institute of Medical Sciences, PakistanCompletedPostpartum Contraception | Family Planning | Reproductive HealthPakistan
-
Jimma UniversityWollo UniversityCompletedPostpartum Family Planning | Modern Contraceptive UseEthiopia
-
Aga Khan UniversityCompletedPostpartum Family PlanningPakistan
-
JhpiegoUnited States Agency for International Development (USAID); Bill and Melinda...CompletedPregnancy | Contraception | Contraceptive Usage | Prenatal Care | Postpartum Family PlanningEthiopia
-
Population Services InternationalActive, not recruitingAntenatal Care | Postpartum Family Planning | Pre-conceptual Care | Adolescent Maternal HealthKenya
-
John James ParkerClínica de Familia La Romana, Dominican RepublicEnrolling by invitationMental Health | Care Coordination | Family Planning | Primary Care | Postpartum CareDominican Republic
-
Assiut UniversityNot yet recruiting
-
RANDMakerere UniversityNot yet recruitingFamily Planning
Clinical Trials on PROMPTS Enhanced Family Planning Counselling
-
Adiyaman UniversityNot yet recruitingContraceptionTurkey (Türkiye)
-
Johns Hopkins Bloomberg School of Public HealthBill and Melinda Gates Foundation; Kwame Nkrumah University of Science and...CompletedContraceptionGhana, United States
-
Adwin Life CareSonal Foundation, India; Gyaansanjeevani, Jhunjhunu, Rajasthan, India; Khatri...CompletedAbuse Neglect Social | Deprivation, Maltreatment Syndrome (Infant or Child)India
-
University of UtahDepartment of Health and Human ServicesCompletedPregnancy | FertilityUnited States, Canada
-
University of VictoriaUniversity of British Columbia; Canadian Institutes of Health Research (CIHR); Dalhousie UniversityCompleted
-
Virginia Commonwealth UniversityAgency for Healthcare Research and Quality (AHRQ)CompletedMental Health | Health Behavior | Multiple Chronic Conditions | Social Determinants of HealthUnited States
-
University of PittsburghCompletedPregnancy | ViolenceUnited States
-
University of Texas at AustinDepartment of Health and Human ServicesCompleted
-
Makerere UniversityMinistry of Health, Uganda; Rakai Health Sciences ProjectActive, not recruiting
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedGynecologic Cancer | Gastrointestinal CancerUnited States